- Home
- FUBO vs REPL Comparison
FUBO vs REPL Comparison
Compare FUBO & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUBO
- REPL
- Stock Information
- Founded
- FUBO 2009
- REPL 2015
- Country
- FUBO United States
- REPL United States
- Employees
- FUBO N/A
- REPL N/A
- Industry
- FUBO Broadcasting
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- FUBO Industrials
- REPL Health Care
- Exchange
- FUBO Nasdaq
- REPL Nasdaq
- Market Cap
- FUBO 681.7M
- REPL 690.7M
- IPO Year
- FUBO 2020
- REPL 2018
- Fundamental
- Price
- FUBO $1.65
- REPL $11.85
- Analyst Decision
- FUBO Buy
- REPL Strong Buy
- Analyst Count
- FUBO 6
- REPL 5
- Target Price
- FUBO $2.88
- REPL $24.00
- AVG Volume (30 Days)
- FUBO 6.6M
- REPL 703.2K
- Earning Date
- FUBO 11-01-2024
- REPL 11-05-2024
- Dividend Yield
- FUBO N/A
- REPL N/A
- EPS Growth
- FUBO N/A
- REPL N/A
- EPS
- FUBO N/A
- REPL N/A
- Revenue
- FUBO $1,524,428,000.00
- REPL N/A
- Revenue This Year
- FUBO $20.59
- REPL N/A
- Revenue Next Year
- FUBO $13.03
- REPL $511.76
- P/E Ratio
- FUBO N/A
- REPL N/A
- Revenue Growth
- FUBO 29.03
- REPL N/A
- 52 Week Low
- FUBO $1.10
- REPL $4.92
- 52 Week High
- FUBO $3.82
- REPL $15.18
- Technical
- Relative Strength Index (RSI)
- FUBO 55.79
- REPL 51.13
- Support Level
- FUBO $1.56
- REPL $11.09
- Resistance Level
- FUBO $1.65
- REPL $11.68
- Average True Range (ATR)
- FUBO 0.08
- REPL 0.60
- MACD
- FUBO 0.02
- REPL -0.05
- Stochastic Oscillator
- FUBO 78.00
- REPL 48.52
About FUBO fuboTV Inc.
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segment of the group is Streaming. It has a business presence in the United States and other international countries.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.